inp.polri.go.id – The Ministry of Health of the Republic of Indonesia explained that the success rate of fomepizole for acute kidney failure patients reached 95%, and became a benchmark for the Ministry of Health to provide fomepizole as an antidote to cure acute kidney failure. "We will use fomepizole because the success rate of fomepizole reached 95%," said Siti Nadia Tarmizi, Head of the Communications and Public Service Bureau of the Ministry of Health. Fomepizole was administered directly to patients with progressive A-typical acute renal failure. Furthermore, Siti Nadia Tarmizi revealed that the antidote also affects the mortality rate of patients with acute kidney failure. Since October 27, 2022, the number of patients who died has reached zero. "So with this fomepizole, we see that there is a progress with its 95% success rate in curing the disease and from this we also see that the death rate of the acute kidney failure since October 27 has reached zero, whic previously had an average of 3-4 victims," explained Siti Nadia quoted from health.okezone.com, Wednesday, (02/10/22)